These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 32144625

  • 1. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L, Du J, Liu J, Liao H, Liu X, Guo X, Liang J, Han H, Yang L, Zhou Y.
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
    Liao H, Pan LL, Du J, Gao N, Wang T.
    Zhonghua Nei Ke Za Zhi; 2019 Jun 01; 58(6):444-448. PubMed ID: 31159524
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E, Franchini S, Papa M, Sabbadini MG, Baldissera E.
    J Rheumatol; 2013 Dec 01; 40(12):2047-51. PubMed ID: 24187104
    [Abstract] [Full Text] [Related]

  • 7. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH.
    Arthritis Care Res (Hoboken); 2012 Nov 01; 64(11):1720-9. PubMed ID: 22674883
    [Abstract] [Full Text] [Related]

  • 8. Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study.
    Wang J, Kong X, Ma L, Ding Z, Chen H, Chen R, Jin X, Chen C, Lin J, Jiang L.
    Rheumatology (Oxford); 2024 May 02; 63(5):1359-1367. PubMed ID: 37540159
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
    Yoshifuji H.
    Mod Rheumatol; 2019 Mar 02; 29(2):287-293. PubMed ID: 30427262
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.
    Fujita Y, Tomiita M, Saida S, Omura S, Sato M, Otsubo Y, Takagi Y, Kano Y, Sekine K, Fukushima K, Kuwashima S, Yoshihara S.
    Mod Rheumatol Case Rep; 2023 Jan 03; 7(1):160-165. PubMed ID: 36018053
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum IL-6 level trajectory for predicting the effectiveness and safety of tocilizumab in the treatment of refractory Takayasu arteritis.
    Sun X, Fang C, Jin S, Li J, Yang Y, Zeng X, Tian X.
    Eur J Intern Med; 2024 Aug 03; 126():77-82. PubMed ID: 38643043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A, Comarmond C, Resche-Rigon M, Mirault T, Kahn JE, Lambert M, Sibilia J, Néel A, Cohen P, Hie M, Berthier S, Marie I, Lavigne C, Anne Vandenhende M, Muller G, Amoura Z, Devilliers H, Abad S, Hamidou M, Guillevin L, Dhote R, Godeau B, Messas E, Cacoub P, Fain O, Saadoun D, French Takayasu Network.
    Circulation; 2015 Nov 03; 132(18):1693-700. PubMed ID: 26354797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
    Kang L, Liu Y, Luo Z, Zhou Y, Chen B, Yin G, Xie Q.
    Front Immunol; 2023 Nov 03; 14():1084558. PubMed ID: 36845158
    [Abstract] [Full Text] [Related]

  • 19. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
    Loricera J, Blanco R, Hernández JL, Castañeda S, Humbría A, Ortego N, Bravo B, Freire M, Melchor S, Mínguez M, Salvatierra J, González-Vela C, Calvo-Río V, Santos-Gómez M, Pina T, González-Gay MA.
    Clin Exp Rheumatol; 2016 Nov 03; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
    Mekinian A, Resche-Rigon M, Comarmond C, Soriano A, Constans J, Alric L, Jego P, Busato F, Cabon M, Dhote R, Estibaliz L, Koné-Paut I, Landron C, Lavigne C, Lioger B, Michaud M, Ruivard M, Sacre K, Gottenberg JE, Gaches F, Goulenok T, Salvarani C, Cacoub P, Fain O, Saadoun D, French Takayasu network.
    J Autoimmun; 2018 Jul 03; 91():55-60. PubMed ID: 29678346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.